Protecting kidney function during anesthesia stays in focus
Bottom line
Version 1
A continuing education session highlighted a familiar but high-stakes challenge in small animal practice: how to anesthetize dogs and cats with pre-existing renal disease without worsening kidney injury. In the Veterinary Practice News session, Kris Kruse-Elliott, DVM, PhD, DACVAA, focused on peri-anesthetic planning, close monitoring, and individualized fluid therapy, with attention to the differences between acute and chronic kidney disease and the need to protect renal perfusion throughout the perioperative period. That approach aligns with broader guidance from AAHA and other veterinary anesthesia resources, which emphasize that no single anesthetic drug is inherently “best” for renal patients; the central goal is maintaining blood pressure, cardiac output, and kidney perfusion. (vetce.events)
Why it matters: For veterinary professionals, the message is less about a new drug or device and more about disciplined case management. Published guidance notes that moderately to severely azotemic patients may benefit from pre-anesthetic stabilization and fluids, while newer reviews caution against one-size-fits-all fluid plans in kidney patients because urine output and fluid tolerance can vary widely. Evidence reviews also raise concerns about synthetic colloids in animals with renal dysfunction, reinforcing the shift toward individualized crystalloid-based support, blood pressure monitoring, and careful postoperative follow-up. (aaha.org)
What to watch: Expect continued discussion around goal-directed fluid therapy, blood pressure targets, and how to balance renal protection with the risk of fluid overload in older, medically complex patients. (frontiersin.org)
Key facts
- Topic
- Anesthesia in dogs and cats with pre-existing renal disease
- Speaker
- Kris Kruse-Elliott, DVM, PhD, DACVAA
- Focus
- Peri-anesthetic planning, close monitoring, and individualized fluid therapy
- Key principle
- No single anesthetic drug is inherently best for renal patients
- Primary goal
- Maintain blood pressure, cardiac output, and kidney perfusion
- Fluid therapy
- Standard maintenance formulas may not apply in kidney dysfunction
- Fluid risk
- Hydroxyethyl starches may carry more risk than benefit in most renal dysfunction cases
- Monitoring
- Blood pressure, urine output, hydration status, and recovery protocols
Version 2
Managing anesthesia in patients with kidney disease remains one of the more nuanced decisions in companion animal medicine, and a recent Veterinary Practice News education session put that challenge back in focus. Kris Kruse-Elliott, DVM, PhD, DACVAA, reviewed how to protect renal function in dogs and cats with pre-existing renal disease through peri-anesthetic planning, vigilant monitoring, and individualized fluid therapy, with discussion spanning acute versus chronic disease and perioperative management. (vetce.events)
The topic lands at a time when veterinary teams are seeing more older pets with chronic comorbidities, including chronic kidney disease. That has made anesthesia planning less about choosing a single “renal-safe” protocol and more about risk stratification and physiologic support. AAHA’s anesthesia guidance has long framed the issue this way, stating that no one anesthetic drug or drug combination is superior for renal disease and that the priority is preserving blood pressure and adequate renal perfusion. The same guidance says some azotemic patients may benefit from pre-anesthetic diuresis and continued postoperative fluids, depending on condition and response. (aaha.org)
That framework is echoed in other peer-reviewed veterinary sources. Colorado State authors writing on anesthesia for renal patients note that these cases can range from asymptomatic to severely compromised, and that management has to be individualized after physical exam and laboratory assessment. They also stress why the stakes are high: the kidneys are especially vulnerable to ischemic injury, so anesthesia-related drops in cardiac output or blood pressure can further compromise function. (assets.ctfassets.net)
The fluid therapy piece is where clinical thinking appears to be evolving. A Frontiers review found there are few evidence-based studies defining ideal IV fluid doses in dogs and cats with kidney dysfunction, and argued that standard maintenance formulas often don’t apply because urine output in these patients can range from marked polyuria to anuria. The review supports tailoring fluid administration to measured losses and changing patient needs, rather than relying on fixed rates. It also notes that, extrapolating from human medicine and limited veterinary evidence, the risks of hydroxyethyl starches may outweigh the benefits in most clinical situations involving renal dysfunction. (frontiersin.org)
Clinical commentary for practitioners points in a similar direction. Clinician’s Brief materials on renal anesthesia and anesthetic hypotension emphasize balanced anesthesia, minimizing anesthetic depth when possible, avoiding drugs that markedly reduce cardiac output or cause vasoconstriction in fragile renal patients, and maintaining arterial pressure high enough to support organ perfusion. In patients with chronic renal insufficiency, especially those with concurrent hypertension, blood pressure targets may need to be higher than the usual minimum thresholds used for otherwise healthy anesthetized dogs and cats. (cliniciansbrief.com)
Why it matters: For general practitioners, emergency clinicians, and technicians, this is a reminder that renal protection during anesthesia is a systems issue. Pre-anesthetic workups, hydration status, urine output assessment, blood pressure monitoring, warming, analgesia planning, and recovery protocols all shape renal outcomes. It also has communication value with pet parents: kidney disease does increase anesthetic complexity, but current guidance suggests the greatest protection comes from stabilization, individualized support, and active monitoring, not from any single drug choice or blanket fluid recipe. (aaha.org)
The discussion may be especially relevant for common procedures such as dentals, imaging, and soft tissue surgery in older cats and dogs, where clinicians often weigh the risks of anesthesia against the risks of delaying care. Veterinary sources note that fluid support and cardiovascular monitoring are particularly important in older cats, many of whom have some degree of renal compromise, but also caution that lower-volume strategies may be needed in species and patients less tolerant of aggressive fluid administration. (cliniciansbrief.com)
What to watch: The next step for the field is likely more data, not just more opinion, on goal-directed fluid therapy, intraoperative blood pressure targets for CKD patients, and which monitoring strategies best predict postoperative kidney outcomes in dogs and cats with chronic renal disease. (frontiersin.org)